To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

No benefit of PRP injections for recovery following grade I/II hamstring injury

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
January 2016

No benefit of PRP injections for recovery following grade I/II hamstring injury

Vol: 5| Issue: 1| Number:77| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:N/A

Rationale, secondary outcome scores and 1-year follow-up of a randomised trial of platelet-rich plasma injections in acute hamstring muscle injury: the Dutch Hamstring Injection Therapy study

Br J Sports Med. 2015 Sep;49(18):1206-12

Contributing Authors:
G Reurink GJ Goudswaard MH Moen A Weir JA Verhaar SM Bierma-Zeinstra M Maas JL Tol Dutch HIT-study Investigators

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

80 patients with grade I or II hamstring injury were randomized to receive two injections of either platelet-rich plasma (PRP) or placebo. The purpose of this study was to compare time to return to sport between groups, as well as evaluate subjective and clinical outcome measures between groups over 26 weeks post-injury and re-injury rate over the first year of follow-up. Results demonstrated no s...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue